Maroussi, Greece – April 1, 2026 – Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), an international shipping company, announced today that its Annual Report on Form 20-F for the year ended December 31, ...

Investing.com - Jefferies raised its price target on Pyxis Oncology Inc. (NASDAQ:PYXS) to $8.00 from $7.40 while maintaining a Buy rating on the stock. The new target represents significant upside ...

Investing.com - William Blair reiterated a Market Perform rating on Pyxis Oncology Inc. (NASDAQ:PYXS) stock. The stock has declined nearly 12% over the past week, currently trading at $1.46 with a ...

Completed target enrollment in Phase 1 monotherapy dose expansion study of micvotabart pelidotin (MICVO) in 2L+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) in the first ...

BOSTON, March 23, 2026 (GLOBE NEWSWIRE)-- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today provided a ...

NEW DELHI: The Pyxis Pioneer, a Singapore-flagged cargo vessel carrying liquefied petroleum gas (LPG) from Texas in the United States, docked at New Mangalore Port in Karnataka’s Mangaluru on ...

A new test firmware build from Blackmagic Design extends phase-detection autofocus to the PYXIS 6K, following its introduction on the Cinema Camera 6K last year. The latest beta version of Blackmagic ...

Pyxis Tankers (NASDAQ:PXS) is gearing up to announce its quarterly earnings on Thursday, 2026-03-05. Here's a quick overview of what investors should know before the release. Analysts are estimating ...

MOL PLUS has decided to invest in Pyxis Maritime, a Singapore-based developer of electric vessels and operator of electric boat charging stations, as part of efforts to promote the commercialization ...

Jesse Calis spent a month with the Blackmagic PYXIS 12K cinema camera. His verdict: “If you are a serious filmmaker… this camera is really for you.” And how. Watch his full review of the Blackmagic ...

Fintel reports that on November 4, 2025, Guggenheim maintained coverage of Pyxis Oncology (NasdaqGS:PYXS) with a Buy recommendation. Analyst Price Forecast Suggests 60.63% Upside As of October 30, ...